SHARE
Vaccines Market

Vaccines - Global Market Outlook (2018-2027)

4.7 (60 reviews)
Published: March 2020 ID: SMRC18981
4.7 (60 reviews)
Published: March 2020 ID: SMRC18981

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Vaccines market is accounted for $38.36 billion in 2018 and is expected to reach $81.27 billion by 2027 growing at a CAGR of 8.7% during the forecast period. While the factors like growing awareness on immunization, strong vaccine pipeline and increasing focus of the key pharmaceutical players to develop innovative vaccines are driving the growth of the market. However, the huge capital investments required for developing vaccines may restrain the market growth. Moreover, the high growth prospects in emerging markets and an increase in the adoption of combination vaccines in prevention strategies by the government provide new growth opportunities in the future.

Vaccines are a powerful way to protect billions of people against many diseases that can be very dangerous and even deadly. A vaccine recognizes foreign invaders and releases the antibodies to destroy them and also provides immunity against that particular disease in the future. Most of the vaccines are given by injection, but some are given orally or nasally.

Based on the distribution channel, the hospital & retail pharmacies are likely to have a huge demand in the forecast period because vaccinations are a shorter duration procedure often conducted at smaller institutions. Also, people prefer nearby vaccination access. Hospital & retail pharmacies across the globe are under government surveillance to ensure vaccines demand is met and have adequate vaccine stock. By geography, North America is estimated to have a huge demand owing to the high prevalence of infectious diseases and growing investments by government and non-government organizations for vaccine development.

Some of the key players in Vaccines Market include Johnson & Johnson, Astrazeneca, Mitsubishi Tanabe Pharma Corporation, Sanofi Pasteur SA, CSL Limited, Emergent Biosolutions Inc, Panacea Biotec LTD, Bharat Biotech, Serum Institute of India Pvt LTD, Bavarian Nordic, Glaxosmithkline PLC, Daiichi Sankyo Company Limited, Pfizer Inc, Biological E, and Merck & Co Inc.

Types Covered:
• Multivalent Vaccines
• Monovalent Vaccines   

Technologies Covered:
• Conjugate Vaccines    
• Recombinant Vaccines   
• Toxoid Vaccines    
• Polysaccharide Vaccines   
• Inactivated & Subunit Vaccines   
• Live Attenuated Vaccines    
• Viral Vaccines    

Distribution Channels Covered:
• Government Suppliers
• Hospital & Retial Pharmacies

 Route of Administration Covered:
• Intradermal    
• Intramuscular and Subcutaneous Administration
• Oral Administration
• Other Routes of Administration

Disease Indications Covered:
• Cancer     
• Cholera     
• Dengue     
• Diphtheria, Pertussis, and Tetanus (DTP)   
• Hepatitis     
• Herpes Zoster    
• Human Papilloma Virus (HPV)    
• Influenza     
• Measles, Mumps, and Rubella (MMR)   
• Meningococcal Disease    
• Pneumococcal Disease   
• Polio      
• Rabies      
• Rotavirus     
• Typhoid Fever    
• Varicella

 

End Users Covered:
• Adult Patients    
• Pediatric Patients    
• Traveler Vaccines


Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan        
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances.

 

1 Executive Summary      
        
2 Preface       

 2.1 Abstract      
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology    
  2.4.1 Data Mining    
  2.4.2 Data Analysis     
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions    
        
3 Market Trend Analysis     
 3.1 Introduction     
 3.2 Drivers      
 3.3 Restraints     
 3.4 Opportunities     
 3.5 Threats      
 3.6 Technology Analysis    
 3.7 End User Analysis     
 3.8 Emerging Markets     
 3.9 Impact of Covid-19    
        
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry     
        
5 Global Vaccines Market, By Type    
 5.1 Introduction     
 5.2 Multivalent Vaccines    
 5.3 Monovalent Vaccines    
        
6 Global Vaccines Market, By Technology    
 6.1 Introduction     
 6.2 Conjugate Vaccines         
 6.3 Recombinant Vaccines        
 6.4 Toxoid Vaccines          
 6.5 Polysaccharide Vaccines         
 6.6 Inactivated & Subunit Vaccines       
 6.7 Live Attenuated Vaccines         
 6.8 Viral Vaccines          
        
7 Global Vaccines Market, By Distribution Channel   
 7.1 Introduction     
 7.2 Government Suppliers    
 7.3 Hospital & Retial Pharmacies    
        
8 Global Vaccines Market, By Route of Administration  
 8.1 Introduction     
 8.2 Intradermal          
 8.3 Intramuscular and Subcutaneous Administration  
 8.4 Oral Administration     
 8.5 Other Routes of Administration   
  8.5.1 Transcutaneous (TC)   
  8.5.2 Nasal Route    
        
9 Global Vaccines Market, By Disease Indication   
 9.1 Introduction     
 9.2 Cancer           
 9.3 Cholera           
 9.4 Dengue           
 9.5 Diphtheria, Pertussis, and Tetanus (DTP)      
 9.6 Hepatitis           
 9.7 Herpes Zoster          
 9.8 Human Papilloma Virus (HPV)        
 9.9 Influenza           
 9.10 Measles, Mumps, and Rubella (MMR)       
 9.11 Meningococcal Disease         
 9.12 Pneumococcal Disease        
 9.13 Polio             
 9.14 Rabies            
 9.15 Rotavirus           
 9.16 Typhoid Fever          
 9.17 Varicella            
        
10 Global Vaccines Market, By End User    
 10.1 Introduction     
 10.2 Adult Vaccines           
 10.3 Pediatric Vaccines     
 10.4 Traveler Vaccines          
        
11 Global Vaccines Market, By Geography  
  
 11.1 Introduction     
 11.2 North America     
  11.2.1 US     
  11.2.2 Canada     
  11.2.3 Mexico     
 11.3 Europe      
  11.3.1 Germany     
  11.3.2 UK     
  11.3.3 Italy     
  11.3.4 France     
  11.3.5 Spain     
  11.3.6 Rest of Europe    
 11.4 Asia Pacific     
  11.4.1 Japan     
  11.4.2 China     
  11.4.3 India     
  11.4.4 Australia     
  11.4.5 New Zealand    
  11.4.6 South Korea    
  11.4.7 Rest of Asia Pacific    
 11.5 South America     
  11.5.1 Argentina    
  11.5.2 Brazil     
  11.5.3 Chile     
  11.5.4 Rest of South America   
 11.6 Middle East & Africa    
  11.6.1 Saudi Arabia    
  11.6.2 UAE     
  11.6.3 Qatar     
  11.6.4 South Africa    
  11.6.5 Rest of Middle East & Africa   
        
12 Key Developments      
 12.1 Agreements, Partnerships, Collaborations and Joint Ventures 
 12.2 Acquisitions & Mergers    
 12.3 New Product Launch    
 12.4 Expansions     
 12.5 Other Key Strategies    
        
13 Company Profiling      
 13.1 Johnson & Johnson                  
 13.2 Astrazeneca                     
 13.3 Mitsubishi Tanabe Pharma Corporation              
 13.4 Sanofi Pasteur SA                    
 13.5 CSL Limited                      
 13.6 Emergent Biosolutions Inc                
 13.7 Panacea Biotec LTD                     
 13.8 Bharat Biotech             
 13.9 Serum Institute of India Pvt LTD                 
 13.10 Bavarian Nordic                   
 13.11 Glaxosmithkline PLC        
 13.12 Daiichi Sankyo Company Limited                 
 13.13 Pfizer Inc                    
 13.14 Biological E                      
 13.15 Merck & Co Inc                   


List of Tables       
1 Global Vaccines Market Outlook, By Region (2017-2027) ($MN) 
2 Global Vaccines Market Outlook, By Type (2017-2027) ($MN)  
3 Global Vaccines Market Outlook, By Multivalent Vaccines (2017-2027) ($MN)
4 Global Vaccines Market Outlook, By Monovalent Vaccines (2017-2027) ($MN)
5 Global Vaccines Market Outlook, By Technology (2017-2027) ($MN) 
6 Global Vaccines Market Outlook, By Conjugate Vaccines (2017-2027) ($MN)
7 Global Vaccines Market Outlook, By Recombinant Vaccines (2017-2027) ($MN)
8 Global Vaccines Market Outlook, By Toxoid Vaccines (2017-2027) ($MN) 
9 Global Vaccines Market Outlook, By Polysaccharide Vaccines (2017-2027) ($MN)
10 Global Vaccines Market Outlook, By Inactivated & Subunit Vaccines (2017-2027) ($MN)
11 Global Vaccines Market Outlook, By Live Attenuated Vaccines (2017-2027) ($MN)
12 Global Vaccines Market Outlook, By Viral Vaccines (2017-2027) ($MN) 
13 Global Vaccines Market Outlook, By Distribution Channel (2017-2027) ($MN)
14 Global Vaccines Market Outlook, By Government Suppliers (2017-2027) ($MN)
15 Global Vaccines Market Outlook, By Hospital & Retial Pharmacies (2017-2027) ($MN)
16 Global Vaccines Market Outlook, By Route of Administration (2017-2027) ($MN)
17 Global Vaccines Market Outlook, By Intradermal (2017-2027) ($MN) 
18 Global Vaccines Market Outlook, By Intramuscular and Subcutaneous Administration (2017-2027) ($MN)
19 Global Vaccines Market Outlook, By Oral Administration (2017-2027) ($MN)
20 Global Vaccines Market Outlook, By Other Routes of Administration (2017-2027) ($MN)
21 Global Vaccines Market Outlook, By Transcutaneous (TC) (2017-2027) ($MN)
22 Global Vaccines Market Outlook, By Nasal Route (2017-2027) ($MN) 
23 Global Vaccines Market Outlook, By Disease Indication (2017-2027) ($MN)
24 Global Vaccines Market Outlook, By Cancer (2017-2027) ($MN) 
25 Global Vaccines Market Outlook, By Cholera (2017-2027) ($MN) 
26 Global Vaccines Market Outlook, By Dengue (2017-2027) ($MN) 
27 Global Vaccines Market Outlook, By Diphtheria, Pertussis, and Tetanus (DTP) (2017-2027) ($MN)
28 Global Vaccines Market Outlook, By Hepatitis (2017-2027) ($MN) 
29 Global Vaccines Market Outlook, By Herpes Zoster (2017-2027) ($MN) 
30 Global Vaccines Market Outlook, By Human Papilloma Virus (HPV) (2017-2027) ($MN)
31 Global Vaccines Market Outlook, By Influenza (2017-2027) ($MN) 
32 Global Vaccines Market Outlook, By Measles, Mumps, and Rubella (MMR) (2017-2027) ($MN)
33 Global Vaccines Market Outlook, By Meningococcal Disease (2017-2027) ($MN)
34 Global Vaccines Market Outlook, By Pneumococcal Disease (2017-2027) ($MN)
35 Global Vaccines Market Outlook, By Polio (2017-2027) ($MN)  
36 Global Vaccines Market Outlook, By Rabies (2017-2027) ($MN)  
37 Global Vaccines Market Outlook, By Rotavirus (2017-2027) ($MN) 
38 Global Vaccines Market Outlook, By Typhoid Fever (2017-2027) ($MN) 
39 Global Vaccines Market Outlook, By Varicella (2017-2027) ($MN) 
40 Global Vaccines Market Outlook, By End User (2017-2027) ($MN) 
41 Global Vaccines Market Outlook, By Adult Vaccines (2017-2027) ($MN) 
42 Global Vaccines Market Outlook, By Pediatric Vaccines(2017-2027) ($MN)
43 Global Vaccines Market Outlook, By Traveler Vaccines (2017-2027) ($MN)
        
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials